71335-2972 Ondansetron

Product NDC:

71335-2972

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 4.0

Unit: mg/1

Packages:

Code: 71335-2972-01

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-1)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-02

Description: 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-2)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-03

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-3)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-04

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-4)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-05

Description: 15 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-5)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-6)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-07

Description: 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-7)

Effective Date: Oct. 29, 2025

Discontinued:

Code: 71335-2972-08

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-8)

Effective Date: Oct. 29, 2025

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC